On the public citation graph

Early-Stage Hodgkin's Lymphoma

https://doi.org/10.1056/nejmra1003733
0 signed · 208 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/1097-0142(197808)42:2<787::aid-cncr2820420251>3.0.co;2-4openalex-snapshot
Childhood Hodgkin's disease in Uganda.A ten year experience
inferredcites →https://doi.org/10.1002/ajh.21547openalex-snapshot
Management of hematological malignancies during pregnancy
inferredcites →https://doi.org/10.1016/b978-012448510-5/50151-5openalex-snapshot
Commentary on and reprint of Kaplan HS, The radical radiotherapy of regionally localized Hodgkin's disease, in Radiology (1962) 78:553–561
inferredcites →https://doi.org/10.1016/j.ahj.2004.12.026openalex-snapshot
Diastolic dysfunction after mediastinal irradiation
inferredcites →https://doi.org/10.1016/s0140-6736(72)92088-0openalex-snapshot
CHEMOTHERAPY OF CHILDHOOD HODGKIN'S DISEASE IN UGANDA
inferredcites →https://doi.org/10.1016/s0140-6736(73)92483-5openalex-snapshot
Epidemiology of Hodgkin's Disease
inferredcites →https://doi.org/10.1016/s1470-2045(09)70258-xopenalex-snapshot
Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC–GELA H8 randomised controlled trial
inferredcites →https://doi.org/10.1056/nejm198703193161203openalex-snapshot
Decreasing Risk of Leukemia with Prolonged Follow-up after Chemotherapy and Radiotherapy for Hodgkin's Disease
inferredcites →https://doi.org/10.1056/nejm199811193392104openalex-snapshot
A Prognostic Score for Advanced Hodgkin's Disease
inferredcites →https://doi.org/10.1056/nejmoa064601openalex-snapshot
Chemotherapy plus Involved-Field Radiation in Early-Stage Hodgkin's Disease
inferredcites →https://doi.org/10.1056/nejmoa1000067openalex-snapshot
Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma
inferredcites →https://doi.org/10.1093/annonc/mdh044openalex-snapshot
Factors influencing treatment recommendations in early-stage Hodgkin’s disease: a survey of physicians
inferredcites →https://doi.org/10.1093/annonc/mdh465openalex-snapshot
Treatment of stage I and II Hodgkin's lymphoma with ABVD chemotherapy: results after 7 years of a prospective study
inferredcites →https://doi.org/10.1093/annonc/mdl063openalex-snapshot
Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter study
inferredcites →https://doi.org/10.1093/annonc/mdl302openalex-snapshot
Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials
inferredcites →https://doi.org/10.1093/annonc/mdl379openalex-snapshot
Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group
inferredcites →https://doi.org/10.1093/annonc/mdm575openalex-snapshot
ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma: results from an Intergruppo Italiano Linfomi randomized study
inferredcites →https://doi.org/10.1093/annonc/mdp071openalex-snapshot
Prognostic significance of mid- and post-ABVD PET imaging in Hodgkin's lymphoma: the importance of involved-field radiotherapy
inferredcites →https://doi.org/10.1093/jnci/94.3.182openalex-snapshot
Lung Cancer Following Chemotherapy and Radiotherapy for Hodgkin's Disease
inferredcites →https://doi.org/10.1093/jnci/95.13.971openalex-snapshot
Roles of Radiation Dose, Chemotherapy, and Hormonal Factors in Breast Cancer Following Hodgkin's Disease
inferredcites →https://doi.org/10.1093/jnci/dji290openalex-snapshot
Cumulative Absolute Breast Cancer Risk for Young Women Treated for Hodgkin Lymphoma
inferredcites →https://doi.org/10.1093/jnci/djk029openalex-snapshot
Myocardial Infarction Mortality Risk After Treatment for Hodgkin Disease: A Collaborative British Cohort Study
inferredcites →https://doi.org/10.1093/jnci/djp147openalex-snapshot
Increased Risk of Stroke and Transient Ischemic Attack in 5-Year Survivors of Hodgkin Lymphoma
inferredcites →https://doi.org/10.1136/bmj.1.5347.1704openalex-snapshot
Cure of Hodgkin's Disease
inferredcites →https://doi.org/10.1148/78.4.553openalex-snapshot
The Radical Radiotherapy of Regionally Localized Hodgkin's Disease
inferredcites →https://doi.org/10.1182/blood-2004-04-1311openalex-snapshot
Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease
inferredcites →https://doi.org/10.1182/blood-2006-07-034405openalex-snapshot
Late cardiotoxicity after treatment for Hodgkin lymphoma
inferredcites →https://doi.org/10.1182/blood-2008-11-191890openalex-snapshot
Early chromatin unfolding by RUNX1: a molecular explanation for differential requirements during specification versus maintenance of the hematopoietic gene expression program
inferredcites →https://doi.org/10.1182/blood.v108.11.33.33openalex-snapshot
Consolidation with Alemtuzumab Improves Progression-Free Survival in Patients with Chronic Lymphocytic Leukemia (CLL) in First Remission - Long-Term Follow-Up of a Randomized Phase III Trial of the German CLL Study Group (GCLLSG).
inferredcites →https://doi.org/10.1182/blood.v108.11.98.98openalex-snapshot
A Prospective Trial of Radiation Alone vs Combination Chemotherapy Alone for Early-Stage Hodgkin’s Disease: Implications of 25-Year Follow-Up to Current Combined Modality Therapy.
inferredcites →https://doi.org/10.1182/blood.v112.11.1453.1453openalex-snapshot
Early Interim FDG-PET Scan Predicts Outcome in Non-Bulky Limited Stage Hodgkin Lymphoma, but may Not Guide Use of Consolidative Radiotherapy.
inferredcites →https://doi.org/10.1182/blood.v112.11.518.518openalex-snapshot
Regulation of Jak2 Kinase Gene by the Mir-135 Family in Classical Hodgkin Lymphoma
inferredcites →https://doi.org/10.1182/blood.v114.22.717.717openalex-snapshot
Combined Modality Treatment with Intensified Chemotherapy and Dose-Reduced Involved Field Radiotherapy in Patients with Early Unfavourable Hodgkin Lymphoma (HL): Final Analysis of the German Hodgkin Study Group (GHSG) HD11 Trial.
inferredcites →https://doi.org/10.1200/jco.1995.13.5.1080openalex-snapshot
Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report.
inferredcites →https://doi.org/10.1200/jco.20.4.1087openalex-snapshot
Hodgkin's Disease in the Elderly: Improved Treatment Outcome With a Doxorubicin-Containing Regimen
inferredcites →https://doi.org/10.1200/jco.2001.19.6.1610openalex-snapshot
Lung Cancer After Hodgkin’s Disease: A Nested Case-Control Study of the Relation to Treatment
inferredcites →https://doi.org/10.1200/jco.2003.03.023openalex-snapshot
Involved-Field Radiotherapy Is Equally Effective and Less Toxic Compared With Extended-Field Radiotherapy After Four Cycles of Chemotherapy in Patients With Early-Stage Unfavorable Hodgkin’s Lymphoma: Results of the HD8 Trial of the German Hodgkin’s Lymphoma Study Group
inferredcites →https://doi.org/10.1200/jco.2004.09.109openalex-snapshot
Cardiovascular Status in Long-Term Survivors of Hodgkin's Disease Treated With Chest Radiotherapy
inferredcites →https://doi.org/10.1200/jco.2004.12.170openalex-snapshot
ABVD Plus Subtotal Nodal Versus Involved-Field Radiotherapy in Early-Stage Hodgkin's Disease: Long-Term Results
inferredcites →https://doi.org/10.1200/jco.2005.05.2746openalex-snapshot
Combined-Modality Therapy for Clinical Stage I or II Hodgkin's Lymphoma: Long-Term Results of the European Organisation for Research and Treatment of Cancer H7 Randomized Controlled Trials
inferredcites →https://doi.org/10.1200/jco.2005.09.085openalex-snapshot
Randomized Comparison of ABVD Chemotherapy With a Strategy That Includes Radiation Therapy in Patients With Limited-Stage Hodgkin’s Lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group
inferredcites →https://doi.org/10.1200/jco.2009.24.0945openalex-snapshot
Early-Stage, Lymphocyte-Predominant Hodgkin's Lymphoma: Patient Outcomes From a Large, Single-Institution Series With Long Follow-Up
inferredcites →https://doi.org/10.1200/jco.2009.24.9516openalex-snapshot
Transformation to Aggressive Lymphoma in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma
inferredcites →https://doi.org/10.1200/jco.2009.25.3260openalex-snapshot
Treatment of Favorable, Limited-Stage Hodgkin's Lymphoma With Chemotherapy Without Consolidation by Radiation Therapy
inferredcites →https://doi.org/10.7326/0003-4819-73-6-881openalex-snapshot
Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4960603openalex-extracted
Knowledge Growth and Specialization: Evidence from Oncologists
inferred← citeshttps://doi.org/10.1002/9781118158562.ch16openalex-snapshot
Reactive Lymphadenopathy with Sinus Pattern
inferred← citeshttps://doi.org/10.1002/9781118863282.ch18openalex-snapshot
Hodgkin lymphoma
inferred← citeshttps://doi.org/10.1002/9781444323160.ch34openalex-snapshot
Hodgkin Lymphoma
inferred← citeshttps://doi.org/10.1002/9783527838561.ch4openalex-snapshot
Cancers of the Blood
inferred← citeshttps://doi.org/10.1002/cncr.26228openalex-snapshot
Does “in situ lymphoma” occur as a distinct step in the development of nodular lymphocyte‐predominant Hodgkin lymphoma?
inferred← citeshttps://doi.org/10.1002/cncr.27873openalex-snapshot
ABVD alone and a PET scan complete remission negates the need for radiologic surveillance in early‐stage, nonbulky Hodgkin lymphoma
inferred← citeshttps://doi.org/10.1002/cncr.29277openalex-snapshot
Very low utility of surveillance imaging in early‐stage classic H odgkin lymphoma treated with a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine and radiation therapy
inferred← citeshttps://doi.org/10.1002/hon.993openalex-snapshot
In situ follicular lymphoma: pathologic characteristics and diagnostic features
inferred← citeshttps://doi.org/10.1002/ijc.70305openalex-snapshot
Epidemiological evidence for the role of puberty and immune senescence in Hodgkin lymphoma aetiology from 1992 Danish cases
inferred← citeshttps://doi.org/10.1002/pbc.27426openalex-snapshot
Increased clinical trial enrollment among adolescent and young adult cancer patients between 2006 and 2012–2013 in the United States
inferred← citeshttps://doi.org/10.1007/978-0-387-92920-0openalex-snapshot
Handbook of Mathematical Methods in Imaging
inferred← citeshttps://doi.org/10.1007/978-1-4614-3320-0_39openalex-snapshot
Adults with Palpable Neck Mass: Evidence-Based Neuroimaging
inferred← citeshttps://doi.org/10.1007/978-1-4614-3764-2_45openalex-snapshot
Diagnosis and Treatment of Hodgkin’s Lymphoma
inferred← citeshttps://doi.org/10.1007/978-1-4614-8444-8_5openalex-snapshot
MicroRNAs in Hematologic Malignancies
inferred← citeshttps://doi.org/10.1007/978-1-4939-0790-8_45openalex-snapshot
Mathematical Methods in PET and SPECT Imaging
inferred← citeshttps://doi.org/10.1007/978-3-030-25610-4_3openalex-snapshot
Immunotherapy in Hodgkin Lymphoma and Other CD30+ Lymphomas
inferred← citeshttps://doi.org/10.1007/978-3-030-32482-7_14openalex-snapshot
Optimizing Decision Making in Hodgkin Lymphoma
inferred← citeshttps://doi.org/10.1007/978-3-319-28800-0_14openalex-snapshot
Managing Lymphoma During Pregnancy
inferred← citeshttps://doi.org/10.1007/978-3-319-31797-7_3openalex-snapshot
PET Response-Adapted Treatment in Hodgkin Lymphoma
inferred← citeshttps://doi.org/10.1007/978-3-319-35153-7_30openalex-snapshot
Pathology and Molecular Pathology of Hematologic Malignancies
inferred← citeshttps://doi.org/10.1007/978-3-319-64263-5_43openalex-snapshot
Diagnosis and Treatment of Hodgkin Lymphoma
inferred← citeshttps://doi.org/10.1007/978-3-642-02202-9_347openalex-snapshot
Hodgkin Disease
inferred← citeshttps://doi.org/10.1007/978-3-642-27795-5_45-3openalex-snapshot
Mathematical Methods in PET and SPECT Imaging
inferred← citeshttps://doi.org/10.1007/s00259-016-3560-9openalex-snapshot
Lymphoma: current status of clinical and preclinical imaging with radiolabeled antibodies
inferred← citeshttps://doi.org/10.1007/s00277-011-1262-8openalex-snapshot
Hodgkin’s lymphoma—long-term outcome: an experience from a tertiary care cancer center in North India
inferred← citeshttps://doi.org/10.1007/s00520-015-2961-9openalex-snapshot
Supportive/palliative care in cancer patients: quo vadis?
inferred← citeshttps://doi.org/10.1007/s10147-021-02085-6openalex-snapshot
Efficacy and safety of nivolumab combined with brentuximab vedotin after nivolumab monotherapy failure in patients with relapsed and refractory classic Hodgkin lymphoma
inferred← citeshttps://doi.org/10.1007/s11899-011-0092-zopenalex-snapshot
The Importance of Testing PET-Directed Therapy in Patients with Hodgkin Lymphoma
inferred← citeshttps://doi.org/10.1007/s11899-012-0128-zopenalex-snapshot
Appropriate Surveillance for Late Complications in Patients in Remission from Hodgkin Lymphoma
inferred← citeshttps://doi.org/10.1007/s11899-021-00604-wopenalex-snapshot
A New Target for Hodgkin Lymphoma - Camidanlumab Tesirine
inferred← citeshttps://doi.org/10.1007/s12288-015-0559-5openalex-snapshot
Improving Outcome of Hodgkins Disease with Autologous Hematopoietic Stem Cell Transplantation
inferred← citeshttps://doi.org/10.1007/s12288-024-01735-9openalex-snapshot
Clinical Profile and Outcome of Adult Classical Hodgkin’s Lymphoma: Real World Single Centre Experience
inferred← citeshttps://doi.org/10.1007/s12672-025-03792-6openalex-snapshot
The role of liquid biopsy in the management of concurrent Hodgkin lymphoma and ovarian carcinoma treated with nivolumab
inferred← citeshttps://doi.org/10.1007/s13193-025-02509-zopenalex-snapshot
Current Practices in Axillary Management for Clinically Node-Negative Breast Cancer among Breast Surgeons in India: a Cross-Sectional Survey Study
inferred← citeshttps://doi.org/10.1007/s13244-015-0407-zopenalex-snapshot
Beyond PET/CT in Hodgkin lymphoma: a comprehensive review of the role of imaging at initial presentation, during follow-up and for assessment of treatment-related complications
inferred← citeshttps://doi.org/10.1007/s13691-021-00510-1openalex-snapshot
Successful treatment with brentuximab vedotine for a patient with very late relapse of limited stage classic Hodgkin lymphoma
inferred← citeshttps://doi.org/10.1007/s40259-013-0077-7openalex-snapshot
Management of Relapsed or Refractory Hodgkin Lymphoma with Second-Generation Antibody–Drug Conjugates: Focus on Brentuximab Vedotin
inferred← citeshttps://doi.org/10.1007/s40336-015-0124-0openalex-snapshot
PET response-adapted clinical trials in Hodgkin lymphoma: a comprehensive review
inferred← citeshttps://doi.org/10.1016/b978-0-323-06969-4.00030-1openalex-snapshot
Lymph nodes
inferred← citeshttps://doi.org/10.1016/b978-0-323-08373-7.00017-0openalex-snapshot
H
inferred← citeshttps://doi.org/10.1016/b978-0-323-47674-4.00102-xopenalex-snapshot
Hodgkin Lymphoma
inferred← citeshttps://doi.org/10.1016/b978-0-7020-7167-6.00052-xopenalex-snapshot
Chemotherapy of malignancy
inferred← citeshttps://doi.org/10.1016/b978-1-4377-0755-7.00490-5openalex-snapshot
Lymphoma
inferred← citeshttps://doi.org/10.1016/b978-1-4377-1604-7.00192-5openalex-snapshot
Hodgkin's Lymphoma
inferred← citeshttps://doi.org/10.1016/b978-1-4557-2865-7.00105-3openalex-snapshot
Hodgkin Lymphoma
inferred← citeshttps://doi.org/10.1016/b978-1-4557-4696-5.00117-2openalex-snapshot
10.1016/b978-1-4557-4696-5.00117-2
inferred← citeshttps://doi.org/10.1016/b978-3-437-21212-3.10048-7openalex-snapshot
Literaturhinweise und Internetadressen
inferred← citeshttps://doi.org/10.1016/b978-84-8086-959-1.00490-9openalex-snapshot
10.1016/b978-84-8086-959-1.00490-9
inferred← citeshttps://doi.org/10.1016/j.beha.2023.101510openalex-snapshot
Hodgkin lymphoma: Focus on evolving treatment paradigms
inferred← citeshttps://doi.org/10.1016/j.bjhh.2015.03.011openalex-snapshot
Outcomes in relapsed Hodgkin's lymphoma treated with autologous and allogeneic hematopoietic cell transplantation at the Pontificia Universidad Católica de Chile
inferred← citeshttps://doi.org/10.1016/j.blre.2012.04.001openalex-snapshot
Treatment of newly diagnosed advanced stage Hodgkin lymphoma
inferred← citeshttps://doi.org/10.1016/j.blre.2024.101170openalex-snapshot
Harnessing multi-source data for individualized care in Hodgkin Lymphoma
inferred← citeshttps://doi.org/10.1016/j.clml.2013.05.007openalex-snapshot
Vinorelbine, Paclitaxel, Etoposide, Cisplatin, and Cytarabine (VTEPA) Is an Effective Second Salvage Therapy for Relapsed/Refractory Hodgkin Lymphoma
inferred← citeshttps://doi.org/10.1016/j.clml.2017.09.009openalex-snapshot
Treatment Patterns and Outcomes in Early-stage Hodgkin Lymphoma in the Elderly: A National Cancer Database Analysis
inferred← citeshttps://doi.org/10.1016/j.clml.2017.11.003openalex-snapshot
How to Approach a Hodgkin Lymphoma Patient With Relapse After Autologous SCT: Allogeneic SCT
inferred← citeshttps://doi.org/10.1016/j.clml.2018.01.001openalex-snapshot
SOHO State of the Art Updates and Next Questions: Hodgkin Lymphoma
inferred← citeshttps://doi.org/10.1016/j.clml.2025.02.013openalex-snapshot
SOHO State of the Art Updates and Next Questions | Latest Advances in the Management of Primary Mediastinal B-Cell Lymphoma
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2012.07.002openalex-snapshot
Hodgkin lymphoma
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2021.103326openalex-snapshot
The impact of modern radiotherapy on radiation-induced late sequelae: Focus on early-stage mediastinal classical Hodgkin Lymphoma. A critical review by the Young Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
inferred← citeshttps://doi.org/10.1016/j.ctrv.2015.04.006openalex-snapshot
Primary mediastinal large B-cell lymphoma
inferred← citeshttps://doi.org/10.1016/j.emch.2004.08.001openalex-snapshot
Lymphome de Hodgkin de l’adulte
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2013.11.237openalex-snapshot
Thyroid Malignancies in Survivors of Hodgkin Lymphoma
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2014.06.013openalex-snapshot
Low-Dose Chest Computed Tomography for Lung Cancer Screening Among Hodgkin Lymphoma Survivors: A Cost-Effectiveness Analysis
inferred← citeshttps://doi.org/10.1016/j.ijrobp.2014.10.004openalex-snapshot
Radiation Therapy Overcomes Adverse Prognostic Role of Cyclooxygenase-2 Expression on Reed-Sternberg Cells in Early Hodgkin Lymphoma
inferred← citeshttps://doi.org/10.1016/j.jmhi.2014.05.002openalex-snapshot
IL-24: A novel gene therapy candidate for immune system upregulation in Hodgkin’s lymphoma
inferred← citeshttps://doi.org/10.1016/j.lfs.2020.118979openalex-snapshot
Apoptotic regulator BCL-2 blockade as a potential therapy in classical Hodgkin Lymphoma
inferred← citeshttps://doi.org/10.1016/j.tranon.2026.102873openalex-snapshot
PD-1/PD-L1 immune checkpoint inhibitors in Hodgkin lymphoma: A meta- and network meta-analysis
inferred← citeshttps://doi.org/10.1016/s0049-3848(16)30109-8openalex-snapshot
Long-term arterial complications of chemotherapy in patients with cancer
inferred← citeshttps://doi.org/10.1016/s1155-1984(11)55377-4openalex-snapshot
Lymphome de Hodgkin de l'adulte
inferred← citeshttps://doi.org/10.1038/nrclinonc.2012.7openalex-snapshot
Localized non-bulky Hodgkin lymphoma—future questions
inferred← citeshttps://doi.org/10.1038/s41408-021-00518-zopenalex-snapshot
Latest advances in the management of classical Hodgkin lymphoma: the era of novel therapies
inferred← citeshttps://doi.org/10.1053/j.seminoncol.2011.01.008openalex-snapshot
Personalized Treatment of Lymphoma: Promise and Reality
inferred← citeshttps://doi.org/10.1053/j.semnuclmed.2017.09.002openalex-snapshot
Interim FDG-PET Imaging in Lymphoma
inferred← citeshttps://doi.org/10.1055/s-0043-124254openalex-snapshot
Nachsorge bei Krebs: ausgewählte solide Tumore und hämatologische Neoplasien
inferred← citeshttps://doi.org/10.1056/nejmc1009918openalex-snapshot
Colchicine's Other Indication — Effect of FDA Action
inferred← citeshttps://doi.org/10.1056/nejmc1010143openalex-snapshot
Early-Stage Hodgkin's Lymphoma
inferred← citeshttps://doi.org/10.1080/17474086.2018.1516135openalex-snapshot
Determining the sequence of novel therapies in the treatment of relapsed Hodgkin’s lymphoma
inferred← citeshttps://doi.org/10.1089/ct.2014;26.160-161openalex-snapshot
Radiation Therapy for Hodgkin's Lymphoma Predisposes Patients to Thyroid Cancer
inferred← citeshttps://doi.org/10.1093/annonc/mdr551openalex-snapshot
Lung malignancies after Hodgkin lymphoma: disease characteristics, detection methods and clinical outcome
inferred← citeshttps://doi.org/10.1093/annonc/mdv160openalex-snapshot
Does interim PET increase the value of ABVD in advanced-stage Hodgkin lymphoma?
inferred← citeshttps://doi.org/10.1093/annonc/mdv256openalex-snapshot
The new therapeutical scenario of Hodgkin lymphoma
inferred← citeshttps://doi.org/10.1093/bib/bbz044openalex-snapshot
Implementing the FAIR Data Principles in precision oncology: review of supporting initiatives
inferred← citeshttps://doi.org/10.1093/med/9780198746690.003.0524openalex-snapshot
Hodgkin lymphoma
inferred← citeshttps://doi.org/10.1097/cco.0000000000000379openalex-snapshot
Long-term survival after cancer: at what cost?
inferred← citeshttps://doi.org/10.1097/cco.0b013e328348c6c1openalex-snapshot
How we treat elderly patients with Hodgkin lymphoma
inferred← citeshttps://doi.org/10.1097/coc.0000000000000294openalex-snapshot
ACR Appropriateness Criteria® Hodgkin Lymphoma—Unfavorable Clinical Stage I and II
inferred← citeshttps://doi.org/10.1097/icb.0000000000000240openalex-snapshot
A CASE OF CHORIORETINOPATHY AS FIRST MANIFESTATION OF HODGKIN'S LYMPHOMA
inferred← citeshttps://doi.org/10.1097/ppo.0000000000000826openalex-snapshot
Radiotherapy in the Modern Treatment of Hodgkin Lymphoma
inferred← citeshttps://doi.org/10.1111/bjh.12230openalex-snapshot
A phase I study of pulse high‐dose vorinostat (V) plus rituximab (R), ifosphamide, carboplatin, and etoposide ( ICE ) in patients with relapsed lymphoma
inferred← citeshttps://doi.org/10.1111/bjh.15255openalex-snapshot
Early‐stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long‐term patient outcomes
inferred← citeshttps://doi.org/10.1111/ejh.13915openalex-snapshot
Clinical characteristics of Australian treatment‐naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry
inferred← citeshttps://doi.org/10.1111/j.1365-2796.2011.02410.xopenalex-snapshot
Chemotherapy only for localized Hodgkin lymphoma
inferred← citeshttps://doi.org/10.1118/1.4734618openalex-snapshot
SU‐C‐BRB‐01: Radiogenic Second Cancer Risk Differences in Female Hodgkin Lymphoma Patients Treated with Proton versus Photon Radiotherapies
inferred← citeshttps://doi.org/10.1120/jacmp.v16i5.5386openalex-snapshot
Late radiation toxicity in Hodgkin lymphoma patients: proton therapy's potential
inferred← citeshttps://doi.org/10.1136/bmj.f4537openalex-snapshot
Cough and weight loss in a young man
inferred← citeshttps://doi.org/10.1136/heartjnl-2015-308765openalex-snapshot
Radiation-induced valvular heart disease
inferred← citeshttps://doi.org/10.1148/radiol.12121015openalex-snapshot
Patients with Testicular Cancer Undergoing CT Surveillance Demonstrate a Pitfall of Radiation-induced Cancer Risk Estimates: The Timing Paradox
inferred← citeshttps://doi.org/10.1155/2011/592470openalex-snapshot
Hemorrhagic Cystitis due to BK Reactivation in a Young Female Treated for Hodgkin-Disease
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-12-2738openalex-snapshot
Serial Diffusion MRI to Monitor and Model Treatment Response of the Targeted Nanotherapy CRLX101
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-13-1024openalex-snapshot
Plasma MicroRNA Are Disease Response Biomarkers in Classical Hodgkin Lymphoma
inferred← citeshttps://doi.org/10.1159/000460819openalex-snapshot
Hodgkin Lymphoma Outcome: A Retrospective Study from 3 Tertiary Centers in Saudi Arabia
inferred← citeshttps://doi.org/10.1159/000484549openalex-snapshot
Utility of Routine Surveillance Imaging for Hodgkin Disease following Autologous Transplant: Experiences from a Single Institution
inferred← citeshttps://doi.org/10.1177/10781552211040182openalex-snapshot
A successful initiation of treatment of Hodgkin's lymphoma with adriamycin-bleomycin-vinblastine-dacarbazine dose reduction in a patient with fulminant hepatic failure and co-infection with human immunodeficiency virus and hepatitis B
inferred← citeshttps://doi.org/10.1177/1545109711431492openalex-snapshot
Characterization of HIV-Associated Hodgkin's Lymphoma in HIV-Infected Patients
inferred← citeshttps://doi.org/10.1177/2040620718786833openalex-snapshot
Update on the role of brentuximab vedotin in classical Hodgkin lymphoma
inferred← citeshttps://doi.org/10.1179/1607845412y.0000000063openalex-snapshot
Outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin lymphoma patients in a centre from Turkey
inferred← citeshttps://doi.org/10.1182/blood-2010-09-288373openalex-snapshot
How I treat relapsed and refractory Hodgkin lymphoma
inferred← citeshttps://doi.org/10.1182/blood-2011-11-394627openalex-snapshot
Expression of COX-2 on Reed-Sternberg cells is an independent unfavorable prognostic factor in Hodgkin lymphoma treated with ABVD
inferred← citeshttps://doi.org/10.1182/blood-2015-05-647412openalex-snapshot
Incidence of breast cancer among female survivors of Hodgkin lymphoma: a US-population–based trend analysis from 1973 to 2011
inferred← citeshttps://doi.org/10.1182/blood-2017-11-812073openalex-snapshot
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma
inferred← citeshttps://doi.org/10.1182/blood.2020007900openalex-snapshot
How I incorporate novel agents into the treatment of classical Hodgkin lymphoma
inferred← citeshttps://doi.org/10.1182/blood.2022015423openalex-snapshot
Response-adapted anti-PD-1–based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE
inferred← citeshttps://doi.org/10.1186/s12885-020-07561-2openalex-snapshot
Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective
inferred← citeshttps://doi.org/10.1200/edbk_433502openalex-snapshot
Paradigm Shifts in Hodgkin Lymphoma Treatment: From Frontline Therapies to Relapsed Disease
inferred← citeshttps://doi.org/10.1200/edbook_am.2013.33.374openalex-snapshot
Limited-Stage Hodgkin Lymphoma: Optimal Chemotherapy and the Role of Radiotherapy
inferred← citeshttps://doi.org/10.1200/jco.2011.40.1661openalex-snapshot
Early-Stage Hodgkin's Lymphoma: In Pursuit of Perfection
inferred← citeshttps://doi.org/10.1200/jco.2012.45.3266openalex-snapshot
Treatment of Children and Adolescents With Hodgkin Lymphoma Without Radiotherapy for Patients in Complete Remission After Chemotherapy: Final Results of the Multinational Trial GPOH-HD95
inferred← citeshttps://doi.org/10.1200/jco.2016.66.4482openalex-snapshot
PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
inferred← citeshttps://doi.org/10.1201/b16389-38openalex-snapshot
Biomarkers in Hodgkin’s Lymphoma
inferred← citeshttps://doi.org/10.12998/wjcc.v9.i21.6041openalex-snapshot
Relapsed/refractory classical Hodgkin lymphoma effectively treated with low-dose decitabine plus tislelizumab: A case report
inferred← citeshttps://doi.org/10.1371/journal.pone.0029263openalex-snapshot
Plasma Biomarkers for Detecting Hodgkin's Lymphoma in HIV Patients
inferred← citeshttps://doi.org/10.1371/journal.pone.0064716openalex-snapshot
MiR-SNPs as Markers of Toxicity and Clinical Outcome in Hodgkin Lymphoma Patients
inferred← citeshttps://doi.org/10.14260/jemds/2016/1125openalex-snapshot
PAEDIATRIC HAEMATOLOGICAL MALIGNANCIES: AN INCIDENCE AND CLINICOPATHOLOGICAL STUDY
inferred← citeshttps://doi.org/10.1556/eujmi.4.2014.2.7openalex-snapshot
Erythrocyte and blood antibacterial defense
inferred← citeshttps://doi.org/10.1586/14737140.2015.1096202openalex-snapshot
PET-directed therapy in Hodgkin lymphoma: Ready for prime time?
inferred← citeshttps://doi.org/10.1586/17474086.2015.1044432openalex-snapshot
Brentuximab vedotin for the treatment of Hodgkin’s lymphoma
inferred← citeshttps://doi.org/10.18502/ijpa.v15i2.3300openalex-snapshot
Serological Evaluation of Anti-Toxoplasma gondii Antibodies in Patients with Acute Leukemia and Lymphoma through Chemotherapy
inferred← citeshttps://doi.org/10.21320/2500-2139-2013-6-3-258-273openalex-snapshot
Hodgkin’s lymphoma and male fertility disorders
inferred← citeshttps://doi.org/10.2147/blctt.s15554openalex-snapshot
Advances in the diagnosis and management of lymphoma
inferred← citeshttps://doi.org/10.2147/blctt.s15565openalex-snapshot
Reduced intensity treatment in early-stage Hodgkin’s lymphoma
inferred← citeshttps://doi.org/10.2147/jbm.s117452openalex-snapshot
Emerging treatment options for the management of Hodgkin's lymphoma: clinical utility of Nivolumab
inferred← citeshttps://doi.org/10.2217/fon-2016-0048openalex-snapshot
Secondary Acute Myeloid Leukemia in Survivors of Hodgkin Lymphoma
inferred← citeshttps://doi.org/10.2217/ijh.13.11openalex-snapshot
Pet Scan Integration in Lymphoma Management
inferred← citeshttps://doi.org/10.2217/ijh.13.21openalex-snapshot
To Scan or Not to Scan? The Value of Radiologic Surveillance in Early-Stage Hodgkin Lymphoma
inferred← citeshttps://doi.org/10.2218/resmedica.v23i1.1250openalex-snapshot
Classical Hodgkin’s Lymphoma: Pathogenesis and Future Treatment Directions
inferred← citeshttps://doi.org/10.23880/cclsj-16000125openalex-snapshot
The Owl-Eyed, Herculean Cancroid- Hodgkin’s Lymphoma
inferred← citeshttps://doi.org/10.26442/18151434.2022.3.201816openalex-snapshot
Modern approaches in relapsed and refractory Hodgkin lymphoma treatment: literature review and own experience
inferred← citeshttps://doi.org/10.3109/10428194.2011.557455openalex-snapshot
Current concepts and controversies in the management of early stage Hodgkin lymphoma
inferred← citeshttps://doi.org/10.3109/10428194.2015.1050668openalex-snapshot
The continued conundrum of Hodgkin lymphoma etiology
inferred← citeshttps://doi.org/10.31435/ijitss.4(48).2025.4167openalex-snapshot
PRIMARY PULMONARY HODGKIN'S LYMPHOMA: A CASE OF DIAGNOSTIC COMPLEXITY AND TREATMENT RESISTANCE
inferred← citeshttps://doi.org/10.31557/apjcc.2020.5.2.107-112openalex-snapshot
Relative Frequencies and Patterns of Malignant Lymphoma in a Reference Centre in Khartoum, Sudan: A Descriptive Study Based on the WHO Classification of Lymphoid Neoplasms
inferred← citeshttps://doi.org/10.3324/haematol.2023.284303openalex-snapshot
Routine consolidation of early stage primary bone lymphoma with radiation therapy does not improve outcomes
inferred← citeshttps://doi.org/10.3389/fcell.2020.576391openalex-snapshot
Recent Update of HDAC Inhibitors in Lymphoma
inferred← citeshttps://doi.org/10.3389/fonc.2022.1047684openalex-snapshot
Incidence of second primary malignancies in women with different stages of breast cancer
inferred← citeshttps://doi.org/10.3389/fonc.2025.1632039openalex-snapshot
Treatment of relapsed or refractory Hodgkin’s lymphoma with lenalidomide combined with PD-1 monoclonal antibody: a case report and literature review
inferred← citeshttps://doi.org/10.3390/cancers14010061openalex-snapshot
Late Cardiological Sequelae and Long-Term Monitoring in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi
inferred← citeshttps://doi.org/10.3390/cancers7010427openalex-snapshot
Implementation of an Analytical Model for Leakage Neutron Equivalent Dose in a Proton Radiotherapy Planning System
inferred← citeshttps://doi.org/10.3390/ijerph17051783openalex-snapshot
Resources-Stratified Guidelines for Classical Hodgkin Lymphoma
inferred← citeshttps://doi.org/10.3390/jcm9051384openalex-snapshot
Treatment of Hodgkin Lymphoma Relapsed after Autologous Stem Cell Transplantation
inferred← citeshttps://doi.org/10.3390/metabo13101079openalex-snapshot
Urinary Metabolic Distinction of Niemann–Pick Class 1 Disease through the Use of Subgroup Discovery
inferred← citeshttps://doi.org/10.36255/exon-publications.lymphoma.2021.managementopenalex-snapshot
Hodgkin Lymphoma: Recent Progress in Overall Management
inferred← citeshttps://doi.org/10.3816/clml.2010.n.086openalex-snapshot
A Decade of Progress in Lymphoma: Advances and Continuing Challenges
inferred← citeshttps://doi.org/10.4103/0971-5851.171550openalex-snapshot
Clinical profile and outcome of adult Hodgkin lymphoma: Experience from a tertiary care institution
inferred← citeshttps://doi.org/10.4137/cmo.s6637openalex-snapshot
Emerging Pharmacotherapy for Relapsed or Refractory Hodgkins Lymphoma: Focus on Brentuximab Vedotin
inferred← citeshttps://doi.org/10.4155/cli.13.70openalex-snapshot
Monoclonal antibody therapy for classical Hodgkin lymphoma
inferred← citeshttps://doi.org/10.4172/2165-7548.1000136openalex-snapshot
Superior Vena Cava Syndrome as the Preliminary Manifestation of Hodgkin’s Lymphoma in A 31 Year Old Female Patient: A Case Report
inferred← citeshttps://doi.org/10.47310/iarjms.2022.v03i04.003openalex-snapshot
Hodgkin Lymphoma in children six years Experience of Children Welfare Teaching Hospital
inferred← citeshttps://doi.org/10.5045/kjh.2012.47.1.8openalex-snapshot
Treatment strategies for Hodgkin lymphoma recurring following autologous hematopoietic stem cell transplantation
inferred← citeshttps://doi.org/10.5603/hem.a2020.0028openalex-snapshot
Konsensus ekspertów Polskiej Grupy Badawczej Chłoniaków w zakresie postępowania w nawrotowym lub opornym na leczenie klasycznym chłoniaku Hodgkina w 2020 roku
inferred← citeshttps://doi.org/10.5772/34419openalex-snapshot
Treatment of Early Stage Hodgkin Lymphoma
inferred← citeshttps://doi.org/10.6004/jnccn.2011.0054openalex-snapshot
Controversies in the Locoregional Management of Head and Neck Cancer
inferred← citeshttps://doi.org/10.70675/70e0fcb6zb34az4277za148z4b8443d78366openalex-snapshot
Telomere Dysfunction And Chromosomal Instability In Hodgkin Lymphoma
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.